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Abstract
Background: Randomised, placebo-controlled trials are needed to provide evidence demonstrating safe, effective
interventions that reduce falls and fractures in the elderly. The quality of a clinical trial is dependent on successful
recruitment of the target participant group. This paper documents the successes and failures of recruiting over 2,000
women aged at least 70 years and at higher risk of falls or fractures onto a placebo-controlled trial of six years duration.
The characteristics of study participants at baseline are also described for this study.
Methods: The Vital D Study recruited older women identified at high risk of fracture through the use of an eligibility
algorithm, adapted from identified risk factors for hip fracture. Participants were randomised to orally receive either
500,000 IU vitamin D3 (cholecalciferol) or placebo every autumn for five consecutive years. A variety of recruitment
strategies were employed to attract potential participants.
Results: Of the 2,317 participants randomised onto the study, 74% (n = 1716/2317) were consented onto the study in
the last five months of recruiting. This was largely due to the success of a targeted mail-out. Prior to this only 541 women
were consented in the 18 months of recruiting. A total of 70% of all participants were recruited as a result of targeted
mail-out. The response rate from the letters increased from 2 to 7% following revision of the material by a public
relations company. Participant demographic or risk factor profile did not differ between those recruited by targeted mail-
outs compared with other methods.
Conclusion: The most successful recruitment strategy was the targeted mail-out and the response rate was no higher
in the local region where the study had extensive exposure through other recruiting strategies. The strategies that were
labour-intensive and did not result in successful recruitment include the activities directed towards the GP medical
centres. Comprehensive recruitment programs employ overlapping strategies simultaneously with ongoing assessment
of recruitment rates. In our experience, and others direct mail-outs work best although rights to privacy must be
respected.
Trial registration: ISRCTN83409867 and ACTR12605000658617.
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Background
It is widely acknowledged that falls and fractures among
older population are a major health problem and are
associated with significant morbidity and reduced quality
of life in Australia [1-4] and in other developed popula-
tions [5,6]. The highest rate of fracture and the highest
number of fractures occur in the oldest sector (70 years
and over) of the female population where 3-5% of the
older population sustain a fracture each year [7,8]. Almost
90% of all hip fractures result from the impact of a fall [9].
Randomised, placebo-controlled trials are needed to pro-
vide evidence demonstrating safe, effective interventions
that reduce falls and fractures in the elderly.
Intervention studies with a fracture outcome require large
sample sizes of older adults yet frail older women are dif-
ficult to recruit onto placebo-controlled trials of long
duration. Power calculations suggest 6,500 to 7,000 per-
son-years of intervention are needed to detect a 22% dif-
ference in fracture rates between the active and placebo
arms of the study population of women aged 70 years and
older [10]. The quality of a clinical trial is dependent on
successful recruitment of the target participant group. Val-
uable time and financial resources can be wasted when
recruitment efforts are ineffective. This paper documents
the successes and failures of recruiting over 2,000 women
aged at least 70 years and at higher risk of falls or fractures
onto a placebo-controlled trial of six years duration. The
characteristics of study participants at baseline are also
described for this study that investigated the role of an
annual large dose of oral vitamin D3 in reducing falls and
fractures in older women. The single-centre study was an
investigator-initiated clinical intervention trial funded
through competitive government research grants.
Methods
Aims
The Vital D Study aimed to demonstrate that an annual
large-dose of vitamin D3 (500,000 IU) would prevent falls
and fractures in older women who are at high risk of these
events. Secondary aims of the study were to demonstrate
that an annual large-dose of vitamin D (1) was a practical
primary health care intervention (2) has a role in the pre-
vention of depressive symptoms and (3) decreases total
healthcare utilisation.
Study Design
The Vital D Study was designed as a double blind, pla-
cebo-controlled trial in which 1,500 women at high risk
of fracture are randomised to receive either 500,000 IU
vitamin D3 (cholecalciferol) or placebo every autumn for
five consecutive years.
The original protocol specified 1,500 women participat-
ing for 5.5 to 6 years allowing for up to 1750 person-years
lost to withdrawal would achieve our target person-years
of intervention. The protocol was later amended to
expand recruitment to 2,300 participants. This new target
would compensate for the 'slower than anticipated' rate of
recruitment in the initial phases of the Vital D Study and
allow the study goals to be achieved within the original
time frame of the grant.
The initial 1500 participants recruited onto the study were
largely residents of the local Barwon Statistical Division.
This electoral division has a total population of 225,000
and consists of a large regional city (Geelong) surrounded
by smaller coastal towns that have a significant propor-
tion of older, retired residents. Recruitment of the extra
800 participants was largely targeted to the retired popu-
lation of the Mornington Peninsula. This region is in the
same state (Victoria) and similar latitude (38° South) but
is located on the opposite side of the bay.
A nested group consisting of 137 participants consented
to be studied more intensively over the duration of the
Vital D Study. The design of this nested study will be
described in detail in a subsequent paper.
The study was approved by the Barwon Health Human
Research Ethics Committee (BH 02/60) and The Univer-
sity of Melbourne's Human Ethics committee (HREC No.
0200700). The study is registered with both the Australian
Clinical Trial Registry (ACTR No. 12605000658617) and
the International Standard Randomised Controlled Trial
Number Register (ISRCTN No. 83409867). This research
was carried out in compliance with the Helsinki Declara-
tion.
Study population
Women aged 70 years and older who fulfilled the defined
criteria for increased risk of fracture were eligible for the
study if they were not taking medication that affected
bone and calcium metabolism at baseline, did not have
renal disease, hypercalcemia, sarcoidosis, tuberculosis or
lymphoma. Potential participants were excluded if their
serum corrected calcium was greater than 2.65 mmol/L,
serum creatinine greater than 150 umol/L or if their cur-
rent medications included any of the following:- vitamin
D greater than 400 IU/day; bisphosphonates, SERMs, HRT
or calcitriol. The target group was community dwelling
women so volunteers were excluded if their current per-
manent residence at recruitment was a high-level care
facility. Participants were not withdrawn if they moved
into high-level care during the course of the study.
Women were judged to be at an increased risk of fracture
if they scored at least 5 points on an algorithm, adapted
from identified risk factors for hip fracture (Table 1)[11].BMC Medical Research Methodology 2009, 9:78 http://www.biomedcentral.com/1471-2288/9/78
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Recruitment
A variety of recruitment strategies were employed to
attract potential participants. These strategies were devel-
oped through past experience of recruiting for smaller
clinical trials; from collaborating with other professionals
who work with the elderly and from team meetings and
'brain storming' during reviews of our recruitment efforts.
The recruitment strategies can be grouped into six catego-
ries:
1. Doctor/Health Professional referral
2. Club presentation
3. Church/Club newsletter
4. 'Word of mouth'
5. Media (newspaper/radio)
6. Targeted mail outs
Statistics were collected on method of recruitment
through standardised questioning at initial contact with
the potential participant.
1. Doctor/Health Professional referral
The original study protocol aimed to recruit a majority of
participants through their local general practitioner (GP)
as the study was designed to be easily translated to clinical
practice. If the study findings were positive it was envis-
aged that elderly women might receive their annual dose
of vitamin D supplementation when they visited their GP
to receive their annual influenza vaccination. To meet this
goal the research team initially directed substantial
recruitment efforts towards engaging the GPs. To help
involve GPs in the Geelong region (n = 200), the research
team obtained the guidelines for accreditation of Contin-
uing Medical Education (CME) Activities from the Royal
Australian College of General Practitioners. A program
was developed and subsequently accredited by the Col-
lege so that GPs could earn their CME activity points by
attending a symposium of 'An Update on Vitamin D and
Table 1: Eligibility algorithm for the Vital D Study: A total score of at least 5 points was needed to be eligible for participation in the 
study.
RISK FACTOR GUIDELINES SCORE PATIENT SCORE
"Faller" Self-reported or assessed as high risk of falling by the Primary Care Physician 5
Any Fracture Since age of 50 years 5
High risk of low vitamin "D" Avoids sun, wears protective/cultural clothing regularly uses sunscreen and/
or have dark skin
5
Osteoporosis Bone density T-score at spine or hip >-2.5 5
Osteopenia Bone density T-score at spine or hip -1.0 to -2.5 2
Aged > 80 years 2
Maternal hip fracture 1
Thinness BMI < 20 or current weight less than that at age 25 1
Self rated health as fair or worse (excellent/good/fair/poor/very poor) 1
Poor vision Self reported or assessed by primary care physician 1
No walking exercise "Do you walk outside your house or yard regularly?" 1
On feet < 4 hours per day 1
Inability to rise from a chair without using arms 1
Caffeine intake > Two cups of coffee or 4 cups of tea per day 1
Smoker Current 1
Long-acting benzodiazepines Current use 1
Anticonvulsant Current use 1
History of thyrotoxicosis 1
Resting pulse > 80/min 1
SCORE ≥ 5 = eligible for Vital D Study 
(Check exclusions listed below)
TOTAL
EXCLUSIONS
Hypercalcemia Baseline serum corrected calcium > 2.65 mmol/L
Bone-trophic medication Current use; HRT, bisphosphonate, SERM, calcitriol, Vitamin D supplement > 400 
IU/day
Renal disease Creatinine > 150 μmol/L or no known renal disease
Sarcoidosis, TB or lymphomaBMC Medical Research Methodology 2009, 9:78 http://www.biomedcentral.com/1471-2288/9/78
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Osteoporosis'. This was also an opportunity to present the
study goals and involve the GPs in recruitment. The sym-
posium was conducted in April 2003 and was followed up
by the research team visiting the medical centres with bro-
chures and posters for the waiting rooms. These visits were
pre-booked with the Practice managers and included a
ten-minute summary presentation on a laptop computer.
Support staff at the medical practices were also encour-
aged to attend. The research team provided a light lunch
as the meetings were commonly scheduled during the
doctors' brief lunch break. To minimise the time commit-
ment of the doctor, the algorithms were electronically
loaded onto the practice medical software package so that
it would automatically appear when the doctor treated
any female patient aged at least 70 years and not currently
on medication that affect bone and calcium metabolism.
For doctors who did not want the electronic reminder, the
study's algorithm was commercially printed onto 'tear-off'
A4 notepads. If an older woman consented to be con-
tacted by the research team the doctor merely had to
adhere a patient's identification label to the algorithm
sheet. The research team collected these algorithm pages
from the administration staff at the practice and would
telephone the potential participant to check eligibility cri-
teria.
2. Club presentation
The research team approached retirement villages, as well
as service clubs and sporting facilities that typically cater
for an older community. The team gave 35 visual presen-
tations about vitamin D and the research project. Prior to
each presentation the event was advertised in the clubs'
newsletter and posters displayed in the clubrooms.
3. Church/Club newsletter
The study advertisement was placed in newsletters that
had a target audience of older females. Where possible the
advertisement appeared in two or three consecutive club
newsletters. These newsletters were often prepared and
distributed by volunteers and the cost to the research team
for the study advertisement was minimal.
4. 'Word of mouth'
Once the study had several hundred women participating,
the team organised morning teas for participants and
invited them to bring a friend. This activity had two goals
(1) to give participants a sense of 'belonging and owner-
ship of the project' and (2) to provide an opportunity for
the friend to potentially enrol in the study.
During the first year of the project, the research team set
up an information stall at the local three-day agricultural
show. To create interest at this stand printing the study
logo give-aways such as pencils and sun visors was inves-
tigated but not used due to the prohibitive expense. Simi-
larly, printing the study logo on milk cartons was also
investigated but rejected on the basis of cost.
5. Media (newspaper/radio)
The Vital D Study featured in local newspapers 12 times
including advertisements (paid) and general interest arti-
cles (no charge). Advertisements were placed in the same
paper consecutively for 2 to 3 weeks. The team also
employed a public relations/media company (Dolphin-
Bewley®  Public Relations; Ocean Grove, Victoria) to
review the study handouts and engage media coverage for
recruitment. The study had a total of three interviews on
radio including one national radio program. A toll-free
phone number was set up so that potential participants
were not discouraged by the cost of telephone calls.
6. Targeted mail outs
The research team gained approval from several govern-
ment agencies to have the recruitment brochures distrib-
uted to women aged 70 years and older on their database.
In each case the study was invoiced for the cost of the
mail-out. The research team supplied the generic bro-
chures/letters and the agencies/government body collated
and posted the information so that confidentiality was
maintained with their clients. The recipient was asked to
complete the enclosed form and return it in the reply-paid
envelope if they were interested in obtaining more infor-
mation. These targeted mail outs were done using the
databases from (1) the local government council's recipi-
ents of meals-on-wheels and home help (n = 2,000), (2)
the public regional hospital (n = 3,600), (3) a large rural
medical centre (n = 800) and (4) Victorian electoral roll
(n = 23,000).
In Australia voting is compulsory for all residents. The Vic-
torian Electoral Commission (VEC) database contains all
adult residents of the region and can be sorted by date of
birth and postal code. The mail-out from the VEC
occurred as two distinct tasks. In the first instance the VEC
was supplied with postcodes of the Barwon Statistical
Division and 15,000 women in the target age group
received letters. The second VEC mail-out was targeted to
8,000 residents of the Mornington Peninsula.
In conjunction with the VEC mail out to the Mornington
Peninsula, the research team sent a letter explaining the
research project to all general practitioners in the region.
Individual letters were not sent to doctors in the Barwon
region as the Vital D Study had been advertised amongst
the general practitioners in several other ways (CME activ-
ity, presentations at the medical centres and local paper
advertisements).BMC Medical Research Methodology 2009, 9:78 http://www.biomedcentral.com/1471-2288/9/78
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Randomisation and blinding
An independent statistician carried out computer ran-
domisation of participants using their unique study iden-
tification numbers and the statistical software Minitab™
(version 13). The randomisation lists of 'active' and 'pla-
cebo' status were then directly emailed to the hospital's
clinical trials pharmacist who was responsible for all dis-
pensing of study medication throughout the trial.
Results
Recruitment
The Vital D study recruited for two years to reach a revised
target of 2,300 participants (June 2003 to 2005). Of the
2,317 participants, 74% (n = 1716/2317) were consented
onto the study in the last five months (February to June
2005). This was largely due to the recruiting success of a
targeted mail-out from the VEC. Prior to this only 541
women were consented in the 18 months of recruiting to
the end of 2004.
A total of 70% of all participants were recruited as a result
of targeted mail-out (Table 2). The response rate from the
letters averaged 7.6% [VEC (n = 1299/15000, 8.7%); local
public hospital (n = 210/3600, 5.8%); Barwon local gov-
ernment aged care recipients (n = 63/2000, 3.2%); a large
rural medical centre (n = 57/800, 7.1%)].
The successful response rate from the mail out of the study
brochure increased from 2 to 7% following revision of the
material by a public relations company. The changes
included a photo of older people replacing our photo of
tablets, removing the word 'research' from the front cover
of the brochure and some simplification of the language
used. The order that the information was presented was
also changed. The PR company charged the study at a dis-
counted 'not for profit' hourly rate and also arranged sev-
eral media - radio and print exposures for recruitment of
participants onto the study.
Only 5% (n = 116/2,317) of the participants were
recruited through their local GP medical centre (Table 2).
Club presentations averaged only one eligible participant
recruited per event (Table 2). The 'bring a friend' morning
tea resulted in 30 new participants from 200 participants
who attended the event. Another 30 participants were
recruited through the media coverage. In total, 6.5% were
recruited collectively through club presentations, church
newsletters, word of mouth and media. The source of
recruitment for 18% of participants (n = 420) was not
documented. This includes at least 155 participants who
contacted the study team but did not remember how they
first heard about the study.
Characteristics of participants from different recruitment 
methods and residential regions
Participant demographic or risk factor profile did not dif-
fer between those recruited by targeted mail-outs com-
pared with other methods ('faller' p = 0.242, 'fracture
prior to 50 years' p = 0.227, 'high risk for low vitamin D'
p = 0.101 or 'osteoporosis' p = 0.597). The median age did
not differ between those recruited by mail-out versus
other methods (median {range} age 76.1 {70.0-91.3}
and 76.2 {70-93.9} years, respectively; p = 0.345). There
were no differences in the proportion of women recruited
by targeted mail-out compared with other recruitment
strategies between those 'eligible and did participate',
those 'eligible but did not participate' and those 'ineligi-
ble' for the study (83%, 81% and 84%, respectively; p =
0.403).
Participant characteristics (Table 3)
Thirty-nine percent of all participants were classified as
'faller' at recruitment (n = 878/2256) and 19% (n = 424/
2256) earned their 5-point eligibility under the criteria of
previous fracture since age 50 years. Another 36% (n =
819/2256) were classified as being at high risk of low vita-
min D at baseline. Only 1% (n = 23/2256) of participants
Table 2: Source of recruitment
Code Recruitment Strategy Eligible-consented Eligible-not 
participating
Ineligible Responded 'NO'* Total Screened
1 Targeted mail outs. 70.3% (1629) (372) (347) (2486) 67.1% (4834)
2 Doctor/Health Professional 
referral
5.0% (116) (57) (28) 2.8% (201)
3 Club presentation 1.5% (34) (5) (2) 0.5% (41)
4 Church/club newsletter 1.5% (37) (10) (12) 0.8% (59)
5 Word of mouth 2.2% (51) (10) (10) 1.0% (71)
6 Media (newspaper/radio) 1.3% (30) (6) (14) 0.7% (50)
7 Other. 18.1% (420) (362) (1166) 27.0% (1948)
% consented participants 100%
% total number screened 32%
(2317/7204)
11%
(822/7204)
21.9%
(1579/7204)
34%
(2486/7204)
100% (7204)
* did not complete algorithmBMC Medical Research Methodology 2009, 9:78 http://www.biomedcentral.com/1471-2288/9/78
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earned their 5-point eligibility through a self-report of
osteoporosis. And only 5% (n = 112/2256) of participants
gained eligibility to the study through multiple two and
one point criteria that summed to five points.
At baseline the median age was 76.0 years (range: 70.0-
93.9 years). The total intervention period for the study
was 6,930 person-years with only 384 person-years lost to
follow-up, which represents only 5.3% of the potential
person-years (7314 p-y).
Withdrawn Participants (Table 4)
As the annual dose of study medication was only admin-
istered during autumn and winter, some women were
consented onto the study up to six months prior to receiv-
ing any study medication. A total of 59 women withdrew
from the study during this period prior to their first dose
of study medication. Their reasons for withdrawal
included illness (17.0%), personal reasons/no reason
(15.3%), old age/dementia (11.9%), wanting to avoid
unnecessary tablets/tests (11.9%) and discouraged by
family or doctor (11.9%). Two participants were also
excluded from the analysis due to a combination of a fail-
ing memory and an excessive number of falls, i.e. more
than two per day. Thus the number of participants was
2,256 (Figure 1).
Two hundred and twenty-six women withdrew from the
study after receiving at least one dose of study medication.
This represents 10% of Vital D participants. The most
common reasons for early withdrawal from the study was
death (38.5%), illness (23.0%), disinterest (13.7%) and
inability due to old age or dementia (8.0%). A lower per-
centage of those recruited through targeted mail out later
withdrew from the study (10.6% {n = 173/1629} vs.
16.3% {n = 112/688, targeted mail out vs. other recruit-
ment methods, respectively; p < 0.001).
Discussion
The most successful recruitment strategy was the targeted
mail-out with 70% of all participants recruited by this
method. The mail out from the VEC was so successful in
the local Barwon/Geelong region that the team decided to
expand the mail out to the Mornington Peninsula and
increase the target number of participants from 1,500 to
2,300. This allowed the study to be completed in the orig-
inal time frame compensating for an initial slow rate of
recruitment. The mail-outs from the government agencies
(VEC, databases from the local public hospital and local
government home-help agency) each resulted in a similar
recruitment rate of five to seven percent (% of participants
recruited out of the total number of letters sent). The tar-
geted mail-out from a large rural medical centre had a
comparable response rate (7.1%).
Table 3: Participant Characteristics
Characteristic
Age - median (range), years 76.0
(70.0 - 93.9)
Total person-years 6925.2
Region
- Barwon 71.3% (n = 1609)
- Mornington Peninsula 23.0% (n = 520)
- Other 5.6% (n = 127)
Eligibility criteria (5 points)
Faller (self-report or local Dr) Yes 38.9% (n = 878/2256)
Prior fracture since 50 years 18.8% (n = 424/2256)
High risk of low vitamin D 36.3% (n = 819/2256)
Osteoporosis diagnosis 1.0% (n = 23/2256)
Totalled 5 from 1 & 2 point criteria 5.0% (n = 112/2256)
Table 4: Withdrawn participants
Participants withdrawn prior to any study 
medication
Participants withdrawn during intervention 
period
Person-years lost to withdrawal 384.2
(n = 59) (n = 226)
Death 8.5% (n = 5) 38.5% (n = 87)
Illness 17.0% (n = 10) 23.0% (n = 52)
Disinterest/too busy 10.2% (n = 6) 13.7% (n = 31)
Old age/dementia 11.9% (n = 7) 8.0% (n = 18)
Personal reasons/no reason 15.3% (n = 9) 6.2% (n = 14)
Discouraged by family or Doctor 6.8% (n = 4) 1.3% (n = 3)
Avoiding unnecessary tablets/tests 11.9% (n = 7) 2.2% (n = 5)
Met exclusionary criteria 11.9% (n = 7)
Other 6.8% (n = 4) 7.0% (n = 16)
Number of participants in parenthesisBMC Medical Research Methodology 2009, 9:78 http://www.biomedcentral.com/1471-2288/9/78
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Recruitment flow chart Figure 1
Recruitment flow chart. * Two participants were excluded from analysis due to a combination of failing memory and exces-
sive number of falls, i.e. more than two per day.
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A majority of participants resided in two distinct regions
(Barwon/Geelong 69.4% and Mornington Peninsula
22.4%). The response rate from the mail-out was no
higher in the local region (Barwon/Geelong) where the
study had extensive exposure through other recruiting
strategies. This was compared to the targeted mail-out at
the Mornington Peninsula where no presentations took
place. However the letter describing the study sent to all
general practitioners in the Mornington region may have
improved their response rate. Since participants were not
asked if they had discussed the study with their GP we are
unable to determine the influence of their local doctor on
recruitment rates. General practitioners in the Barwon/
Geelong region were informed of the study through adver-
tisements in the regional GP Association's newsletter and
the education forum offered to them as part of their con-
tinuing medical education requirement.
Engaging the services of a small public relations company
enhanced the success of the mail-outs. The company
revised the study brochure/information letter. Although
the changes appeared minor, the positive response rate to
the letter increased from 2 to 7%.
The 'bring a friend' morning tea offered to participants in
the early stages of recruitment was also a worthwhile activ-
ity. The morning tea resulted in 30 new participants from
the 200 invited participants.
The strategies that were labour-intensive and did not
result in successful recruitment include the activities
directed towards the GP medical centres. The team spent
considerable time and effort (1) developing the accredited
CME activity for GPs, (2) developing and installing the
electronic version of the screening algorithm that was
compatible with GP medical practice software and (3) giv-
ing approximately 25 presentations to medical staff.
Although referral of potential participants from doctors
and other health professionals comprised the second
most successful recruitment strategy, the method was
labour-intensive and only contributed 7.4% of all partici-
pants. The 'hands-on' approach of public and targeted
presentations was similarly labour-intensive and while
generating a lot of interest about osteoporosis and vita-
min D, this approach averaged only one eligible partici-
pant per presentation.
A majority of the participants with a recruitment method
classified as 'other or not recorded' are likely to have been
contacted through the targeted mail-outs from VEC. This
was a very busy period of recruitment and staff had little
time to follow-up on the unanswered response relating to
the recruitment method. Staffing levels during this recruit-
ment period were 0.8 equivalent full time (EFT) research
scientist, 0.3 EFT research nurse and 0.3 EFT administra-
tive officer. At this time staff were also responsible for the
monthly ascertainment of all falls and fractures of partici-
pants already enrolled onto the study.
Other recruitment reports of clinical trials have identified
similar recruitment rates from direct mail-outs, 'word of
mouth' and posters/brochures. Robinson and colleagues
[12] enrolled 70 families into an obesity prevention trial
for young children and report 66% were obtained through
direct mail-outs; 7% from other sources such as 'word of
mouth' and 3% from posters and brochures. However, in
contrast to our findings, Robinson's team acquired 24%
through newspaper advertisements compared with 1% of
our participants. Earlier research suggests that newspaper
advertisements and media can promote widespread
awareness and a positive image of the study [13]. While
casual feedback from participants suggests this is true, our
similar recruitment rate for the direct mail-outs in the
Mornington region would suggest our advertising strategy
in the local region had little additional impact on the
results from the direct mail-out. The discrepancy in adver-
tising success between the Vital D study and Robinson's
trial may be explained by the different age of participants.
Older people are more likely to have a close relationship
with their local doctor while their vision and age may
impede their ability to be influenced by advertisements in
the local newspaper.
Our rate of recruitment is consistent with that of an inter-
vention trial on vitamin E in adults aged 50 to 80 years.
The VECAT study recruited 1,204 participants in 60 weeks
[14]. Similarly the Vital D team recruited 2,317 older
women over 104 weeks, although 74% were recruited in
the last 20 weeks. The lessons learnt from the initial poor
response rate of Vital D recruitment include changing
strategies earlier when the initial efforts are unsuccessful.
As the study's secondary aim was to demonstrate that this
was a practical primary health care intervention the
research team were reluctant to minimise the GP's
involvement in recruitment. Garrett's study on vitamin E
also reported a lack of recruiting success with direct
approaches to community groups and via general practi-
tioners [14]. Although these researchers suggest their low
response rate from GPs may be due to weak collaborative
links and no follow-up with the doctors by study person-
nel, these reasons are not applicable in the Vital D study.
The team had (1) strong links with a majority of the 200
GPs in the local region, (2) a Chief Investigator that was
also Head of the department of General Practice at The
University of Melbourne and (3) an Associate Investigator
who was president of the local GP Association.
Garrett and colleagues also reported that recruiting via
direct mail-out using the electoral roll was efficient and
cost-effective. Their recruitment rate of 5% from thisBMC Medical Research Methodology 2009, 9:78 http://www.biomedcentral.com/1471-2288/9/78
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method was in agreement with our rate of 7%. Although
Garrett's research team observed that newspaper advertis-
ing was equally cost-effective as the electoral roll mail-out,
their high initial response could not be duplicated in sub-
sequent advertisements [14].
The study has a high retention rate with few participants
choosing to withdraw. The total person-years lost was
only 5.3% of the maximum possible person-years (7,309
person-years) with 3.9% (n = 87/2256) of participants
dying during the course of the study. Casual feedback
from participants suggests that retention rates were
improved by (1) regular phone contact by the same team
members, (2) regular newsletters that included 'fun' staff
profiles and (3) Christmas cards.
The study was designed to investigate the effect of an
annual dose of vitamin D in older women at high risk of
falls and fractures. The eligibility criteria of 5 points scored
on the screening algorithm aimed to identify high-risk
women. Successful recruiting involves both reaching the
target number of participants and selecting individuals
with the appropriate risk profile that satisfies the original
power calculations. While it can be tempting to accept
eager potential participants who are in the correct age
range, the 'healthy volunteer' bias is well-documented
[15]. Based on our eligibility algorithm 22% of potential
participants screened were rejected thus hopefully elimi-
nating the 'healthy volunteer' bias.
Conclusion
It is common for researchers to face recruitment problems
[16] and a successful clinical trial is dependent on recruit-
ment. As reported by other studies, the Vital D team found
it useful to conduct regular meetings to review recruit-
ment strategies and generate new ideas. Comprehensive
recruitment programs employ overlapping strategies
simultaneously [17] with ongoing assessment of recruit-
ment rates [12]. In our experience, and others [12,14]
direct mail-outs work best although rights to privacy must
be respected.
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